当前位置:首页 - 行情中心 - 伟思医疗(688580) - 财务分析 - 现金流量表

伟思医疗

(688580)

  

流通市值:40.94亿  总市值:40.94亿
流通股本:9577.13万   总股本:9577.13万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金246,589,862.04115,221,492.03526,018,082.02366,019,861.6
  收到的税费返还7,206,626.242,574,060.4317,392,902.1613,420,143.32
  收到其他与经营活动有关的现金6,054,947.344,079,852.5811,905,357.3410,738,740.26
  经营活动现金流入小计259,851,435.62121,875,405.04555,316,341.52390,178,745.18
  购买商品、接受劳务支付的现金60,357,681.9636,153,584.27134,203,067.8696,804,106.54
  支付给职工以及为职工支付的现金81,249,784.3248,699,452.07138,100,523.52108,426,858.94
  支付的各项税费37,065,317.5712,540,395.7653,076,975.4240,509,905.29
  支付其他与经营活动有关的现金21,919,076.38,588,188.3653,191,465.0640,031,622.97
  经营活动现金流出小计200,591,860.15105,981,620.46378,572,031.86285,772,493.74
  经营活动产生的现金流量净额59,259,575.4715,893,784.58176,744,309.66104,406,251.44
二、投资活动产生的现金流量:
  收回投资收到的现金1,716,000,000866,000,0003,521,040,327.162,591,000,000
  取得投资收益收到的现金5,834,397.972,550,983.4212,533,301.19,763,745.78
  处置固定资产、无形资产和其他长期资产收回的现金净额66,626,502.9271,342,00041,650,389.38440
  收到的其他与投资活动有关的现金--1,200,0001,761,000
  投资活动现金流入小计1,788,460,900.89939,892,983.423,576,424,017.642,602,525,185.78
  购建固定资产、无形资产和其他长期资产支付的现金90,638,317.5680,726,075.25118,117,619.2586,592,384.92
  投资支付的现金1,816,000,0001,166,000,0003,571,000,0002,591,000,000
  取得子公司及其他营业单位支付的现金--29,648,485-
  支付其他与投资活动有关的现金900,000900,0001,150,0001,150,000
  投资活动现金流出小计1,907,538,317.561,247,626,075.253,719,916,104.252,678,742,384.92
  投资活动产生的现金流量净额-119,077,416.67-307,733,091.83-143,492,086.61-76,217,199.14
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金103,560,041.01-76,569,346.477,571,632.14
  支付其他与筹资活动有关的现金33,939.98-877,282.9434,480.43
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计103,593,980.99-77,446,629.378,006,112.57
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-103,593,980.99--77,446,629.3-78,006,112.57
四、汇率变动对现金及现金等价物的影响-116,597.95-46,718.16-40,814.5514,187.89
五、现金及现金等价物净增加额-163,528,420.14-291,886,025.41-44,235,220.8-49,802,872.38
  加:期初现金及现金等价物余额1,022,971,611.931,022,971,611.931,067,206,832.731,067,206,832.73
  期末现金及现金等价物余额859,443,191.79731,085,586.521,022,971,611.931,017,403,960.35
补充资料:
  净利润100,122,719.93-138,072,645.5-
  资产减值准备64,656.8-430,627.75-
  固定资产和投资性房地产折旧8,788,785.61-15,568,748.69-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧8,788,785.61-15,568,748.69-
  无形资产摊销5,561,881.89-10,974,095.14-
  长期待摊费用摊销534,243.64-1,322,287.81-
  处置固定资产、无形资产和其他长期资产的损失-33,165,689.15-880.57-
  固定资产报废损失152,559.02---
  公允价值变动损失---4,835,413.96-
  财务费用7,626.44-1,308,051.09-
  投资损失-5,834,397.97--12,533,301.1-
  递延所得税1,188,806.08--521,291.88-
  其中:递延所得税资产减少1,215,785.1--455,252.01-
    递延所得税负债增加-26,979.02--66,039.87-
  存货的减少778,315.83--3,900,453.44-
  经营性应收项目的减少-8,743,426.87--35,595,255.84-
  经营性应付项目的增加-12,074,835.34-61,707,447.05-
  其他1,510,930.8-2,481,992.42-
  不涉及现金收支的投资和筹资活动金额其他项目0-159,008.79-
  现金的期末余额859,443,191.79-1,022,971,611.93-
  减:现金的期初余额1,022,971,611.93-1,067,206,832.73-
  现金及现金等价物的净增加额-163,528,420.14--44,235,220.8-
公告日期2026-08-262026-04-282026-04-282025-10-23
审计意见(境内)标准无保留意见
TOP↑